Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Honghefujie Lotion is a Traditional Chinese Medicine (TCM) botanical drug developed and manufactured by Shanxi Buchang Pharmaceutical. It is formulated as a topical solution derived from the extract of the mature kernels (seeds) of *Crataegus pinnatifida* (hawthorn). The product is primarily indicated for the treatment of various gynecological inflammatory conditions, including vulvovaginal candidiasis and non-specific vaginitis. Its therapeutic effects are attributed to its broad-spectrum antimicrobial activity against pathogens such as *Candida albicans*, as well as its anti-inflammatory and antipruritic properties. The lotion is applied externally or as a vaginal wash to alleviate symptoms such as itching, leucorrhea, and local redness by inhibiting pathogen growth and restoring vaginal microecological balance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Honghefujie Lotion.